(Q40865360)

24 September 2017

title

Direct detection of infectious HIV-1 in blood using a centrifugation-indicator cell assay (English)

1 reference

24 September 2017

Harrington R

1

1 reference

24 September 2017

Wu L

series ordinal

2

1 reference

24 September 2017

Pullen H

series ordinal

3

1 reference

24 September 2017

Emerman M

series ordinal

4

1 reference

24 September 2017

publication date

1 July 2000

1 reference

Journal of Virological Methods

24 September 2017

published in

1 reference

24 September 2017

volume

88

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

111-115

1 reference

Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900181-6

7 January 2021

HIV-1 indicator cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900181-6

7 January 2021

Plasma viremia in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900181-6

7 January 2021

Changing the natural history of HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900181-6

7 January 2021

A quantitative bioassay for HIV-1 based on trans-activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900181-6

7 January 2021

Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900181-6

7 January 2021

Improved detection of replication-competent retrovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900181-6

7 January 2021

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900181-6

7 January 2021

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900181-6

7 January 2021

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900181-6

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900181-6

7 January 2021

A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900181-6

7 January 2021

HIV viral load markers in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900181-6

7 January 2021

Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2800%2900181-6

7 January 2021

10.1016/S0166-0934(00)00181-6

Identifiers

DOI

1 reference

24 September 2017

1 reference